Adolescent “Lean PCOS” Is Characterized by Higher Insulin Resistance and Adverse Adipokine Profile
The Journal of Clinical Endocrinology & Metabolism · 2026
DOI: 10.1210/clinem/dgaf606 ↗Kurz gefasst
Fachartikel in der Zeitschrift The Journal of Clinical Endocrinology & Metabolism, 2026. Verfasst von Rachel C Whooten und 6 weiteren Autor:innen. Beteiligte Einrichtung: Division of Pediatric Endocrinology, Department of Pediatrics, Massachusetts General Hospital for Children, Boston, MA 02114, USA. Hauptthemen laut MEDLINE: Polycystic Ovary Syndrome, Insulin Resistance, Adipokines, Thinness. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 51 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NIDDK NIH HHS, NIH HHS, Harvard Pilgrim Health Care Institute.
Abstract (Originalsprache)
Objective
Although polycystic ovary syndrome (PCOS) is associated with high body mass index (BMI), less is known about the cardiometabolic manifestations of PCOS without excess adiposity. Among female adolescents enrolled in the Project Viva longitudinal prebirth cohort, we characterized growth, adiposity, and cardiometabolic biomarkers among those with vs without PCOS, stratified by BMI category.
Methods
We defined PCOS at the mid-teen visit (mean age 17.7 years) as self-reported diagnosis or oligo-anovulation with clinical/biochemical hyperandrogenism. We obtained anthropometric and dual x-ray absorptiometry measurements. Within each BMI category (≥85th percentile vs < 85th percentile), we used unadjusted linear regression to compare growth trajectories, adiposity, and cardiometabolic biomarkers among those with vs without PCOS. We used mixed effects models to visually represent estimated BMI and linear growth trajectories.
Results
Among 358 females with data at the mid-teen visit, n = 51 (14%) participants met our criteria for PCOS. Among females with BMI <85th percentile, those with PCOS (n = 27) had earlier age at peak height velocity [β = -.57 years; 95% confidence interval (CI) −0.96, −0.18], higher Homeostatic Model Assessment of Insulin Resistance (β = .77, 95% CI 0.23, 1.30), and lower adiponectin-leptin ratio (β = −.35, 95% CI −0.65, −0.06) vs without PCOS. Females with BMI ≥85th percentile had similar biomarkers by PCOS status. Adiposity measures did not differ by PCOS status within either BMI category.
Conclusion
Within this population-based cohort, adolescents with PCOS and BMI <85th percentile had greater insulin resistance and adipose tissue dysfunction vs without PCOS. PCOS-associated metabolic dysfunction exist even among adolescents with BMI <85th percentile.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Division of Pediatric Endocrinology, Department of Pediatrics, Massachusetts General Hospital for Children, Boston, MA 02114, USA.
- Division of General Academic, Department of Pediatrics, Massachusetts General Hospital for Children, Boston, MA 02114, USA.
- Division of Chronic Disease Research Across the Life Course, Department of Population Medicine, Harvard Medical School and Harvard Pilgrim Health Care Institute, Boston, MA 02215, USA.
- Department of Epidemiology, Lifecourse Epidemiology of Adiposity and Diabetes Center, Colorado School of Public Health, University of Colorado Denver Anschutz Medical Campus, Aurora, CO 80045, USA.
- Department of Nutrition, T. H. Chan Harvard School of Public Health, Boston, MA 02115, USA.
- Channing Division of Network Medicine, Department of Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston, MA 02115, USA.
ORCID-Profile: Rachel C Whooten, Sheryl L Rifas-Shiman
Förderung
- NIDDK NIH HHS
- NIH HHS
- Harvard Pilgrim Health Care Institute
- NICHD NIH HHS
- NIEHS NIH HHS
- National Institutes of Health
- National Institute of Diabetes and Digestive and Kidney Diseases
Zitieren
APA
Whooten, R. C., Rifas-Shiman, S. L., Aris, I. M., Perng, W., Chavarro, J. E., Oken, E., & Hivert, M. F. (2026). Adolescent “Lean PCOS” Is Characterized by Higher Insulin Resistance and Adverse Adipokine Profile. The Journal of Clinical Endocrinology & Metabolism. https://doi.org/10.1210/clinem/dgaf606
Vancouver
Whooten RC, Rifas-Shiman SL, Aris IM, Perng W, Chavarro JE, Oken E, et al. Adolescent “Lean PCOS” Is Characterized by Higher Insulin Resistance and Adverse Adipokine Profile. The Journal of Clinical Endocrinology & Metabolism. 2026. doi:10.1210/clinem/dgaf606
BibTeX
@article{Whooten2026,
author = {Whooten, Rachel C and Rifas-Shiman, Sheryl L and Aris, Izzuddin M and Perng, Wei and Chavarro, Jorge E and Oken, Emily and Hivert, Marie-France},
title = {Adolescent “Lean PCOS” Is Characterized by Higher Insulin Resistance and Adverse Adipokine Profile},
journal = {The Journal of Clinical Endocrinology & Metabolism},
year = {2026},
doi = {10.1210/clinem/dgaf606}
}
EUVIMED